Company intelligence / Profile preview

Monograph Capital

San Francisco, California, United Statesmonograph.bio ↗

Ownership: Private
Development stage: Other

Overview

Monograph Capital is a transatlantic venture capital firm investing in early and growth-stage life sciences and healthcare businesses. It supports breakthrough therapeutics, diagnostics, and digitally-enabled healthcare through strategic capital and operational expertise. The firm's investments have contributed to several high-profile exits and company launches in biotech and pharma

Modalities: Small moleculeMonoclonal antibodyHydrogel-based drug delivery therapy
Industry: Investors

Partnerships

GSK partnered on founding Ouro MedicinesTPG Life Sciences InnovationNEANorwest Venture PartnersSanofi Ventures

Beyond the preview

Go deeper on Monograph Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monograph Capital.

Explore the full profile